Healthcare costs in the U.S. are once again accelerating faster than overall inflation, a trend that threatens both hospital sustainability and patient affordability.
Surgical innovation has entered a new era with robotic-assisted surgery rapidly gaining traction across specialties, as highlighted by Bain & Company and HCA’s leading role in robotic operations.
In 2024, the Asia-Pacific (APAC) region found itself at a pivotal juncture in digital health and medtech innovation.
The healthcare and life sciences sectors are poised for a significant rebound in 2025, as executives anticipate a surge in mergers and acquisitions (M&A) alongside transformative innovations.
